Anbiyaiee, Amir Ramazii, Mohammad Bajestani, Siamak Soltani Meybodi, Seyed Mohammadmahdi Keivan, Mona Khoshnam, Seyed Esmaeil Farzaneh, Maryam
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Cancer as a progressive and complex disease is caused by early chromosomal changes and stimulated cellular transformation. Previous studies reported that long non-coding RNAs (lncRNAs) play pivotal roles in the initiation, maintenance, and progression of cancer cells. LncRNA activated by TGF-β (ATB) has been shown to be dysregulated in different ty...
Tsamis, Ioannis Gomatou, Georgia Chachali, Stavroula Porfyria Trontzas, Ioannis Panagiotis Patriarcheas, Vasileios Panagiotou, Emmanouil Kotteas, Elias
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Targeted therapy for oncogenic genetic alterations has changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC). Mutations in the BRAF gene are detected in approximately 4% of patients and result in hyper-activation of the MAPK pathway, leading to uncontrolled cellular proliferation. Inhibition of BRAF and its downstream effect...
Farzaneh, Maryam Najafi, Sajad Anbiyaee, Omid Azizidoost, Shirin Khoshnam, Seyed Esmaeil
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Osteosarcoma (OS) is a common and malignant form of bone cancer, which affects children and young adults. OS is identified by osteogenic differentiation and metastasis. However, the exact molecular mechanism of OS development and progression is still unclear. Recently, long non-coding RNAs (lncRNA) have been proven to regulate OS proliferation and ...
Liu, Le Bai, Yuping Xiang, Lin Qi, Wenbo Gao, Lei Li, Xiaomei Li, Haiyuan Wang, Bofang Chen, Hao
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Chemotherapeutic drugs play an important role in the treatment of cancer, but the individual differences of patients' sensitivity to chemotherapeutic drugs and the drug resistance of chemotherapeutic drugs have always been a thorny problem in clinical treatment. In recent years, with the progress in research on human microbiota, gut microbiome play...
Zhang, Wenjie Jiang, Zhengting Tang, Dong
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Colorectal cancer (CRC) is the third most common cancer in the world today, and its incidence and mortality rates are increasing every year. The ease of proliferation and metastasis of CRC has long been an important reason for its high mortality rate. Exosomes serve as key mediators that mediate communication between tumor cells and various other c...
Quintana-Bertó, Raquel Padilla-Iserte, Pablo Gil-Moreno, Antonio Oliver-Pérez, Reyes Coronado, Pluvio J Martín-Salamanca, María Belén Pantoja-Garrido, Manuel Lorenzo, Cristina Beric, Duska Gilabert-Estellés, Juan
...
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
The main goal of this study is to assess the diagnostic agreement between preoperative biopsy and definitive histology of the surgical specimen to determine which sampling method is most suitable for diagnosis of early-stage endometrial cancer. We performed a retrospective multicentric study to assess the correlation between three endometrial sampl...
Kong, Wencui Zhang, Lei Chen, Ying Yu, Zongyang Zhao, Zhongquan
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Non-small cell lung cancer (NSCLC) is the major subtype of lung cancer, which is the leading cause of cancer death worldwide. Tumor-associated macrophages (TAMs) are one of the main non-tumor cells in the tumor microenvironment. Here, we investigated the effect of cancer cell-derived exosomal LINC00313 on the M2 macrophage differentiation in NSCLC ...
Wang, Yaxuan Peng, Zhouying Wang, Yumin Fan, Ruohao Zhang, Hua Jiang, Weihong
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Complete resection combined with postoperative radiotherapy is ideal for skull base chordomas. The recent literature suggests that the degree of surgical resection is the most important prognostic factor. We retrospectively analyzed the clinical data of 16 patients with initial chordoma treated at our center between August 2015 and December 2021 an...
Bonet, Marta González, David Baquedano, José-Enrique García, Elena Altabas, Manuel Casas, Francesc Feltes, Nicolás Ferrer, Ferran Foro, Palmira Fuentes, Rafael
...
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
To reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of Radiation Oncologists in Catalonia dedicated to prostate cancer. A modified Delphi approach was employed to reach consensus on controversial topics in Radiation Oncology on high-risk non-metastatic (eight questions...
Xu, Yingying Liang, Yonghao Yin, Guanghao
Published in
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Triple-positive breast cancer (TPBC) is a tumor that simultaneously expresses estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). Luminal A-like TPBC is a special subtype with a favorable prognosis but benefits less from HER2-targeted therapy. However, little is known about how to identify lumina...